The Interim Results of a Multicenter study of Safety and Efficacy of Vemurafenib and Cytarbine plus Cladribine Therapy in high-risk Pediatric Langerhans cell Histiocytosis with Braf V600E Mutation

被引:0
|
作者
Evseev, Dmitry [1 ]
Osipova, Daria [1 ]
Kalinina, Irina [1 ]
Raykina, Elena [1 ]
Popov, Alexander [1 ]
Kotskaya, Natalia [1 ]
Chernyak, Ekaterina [1 ]
Burtsev, Evgeny [2 ]
Bronin, Gleb [2 ]
Tayshikhina, Irina [2 ]
Purbueva, Bazarma [3 ]
Fink, Olesya [3 ]
Pristanskova, Ekaterina [3 ]
Novitchkova, Galina [1 ]
Maschan, Alexey [1 ]
Maschan, Michael [1 ]
机构
[1] Dmitry Rogachev Natl Res Ctr, Moscow, Russia
[2] Morozovskaya Children City Clin Hosp, Moscow, Russia
[3] Russian Childrens Clin Hosp, Moscow, Russia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S6 / S6
页数:1
相关论文
共 50 条
  • [41] BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy
    Heritier, Sebastien
    Emile, Jean-Francois
    Barkaoui, Mohamed-Aziz
    Thomas, Caroline
    Fraitag, Sylvie
    Boudjemaa, Sabah
    Renaud, Florence
    Moreau, Anne
    Peuchmaur, Michel
    Chassagne-Clement, Catherine
    Dijoud, Frederique
    Rigau, Valerie
    Moshous, Despina
    Lambilliotte, Anne
    Mazingue, Francoise
    Kebaili, Kamila
    Miron, Jean
    Jeziorski, Eric
    Plat, Genevieve
    Aladjidi, Nathalie
    Ferster, Alina
    Pacquement, Helene
    Galambrun, Claire
    Brugieres, Laurence
    Leverger, Guy
    Mansuy, Ludovic
    Paillard, Catherine
    Deville, Anne
    Armari-Alla, Corinne
    Lutun, Anne
    Gillibert-Yvert, Marion
    Stephan, Jean-Louis
    Cohen-Aubart, Fleur
    Haroche, Julien
    Pellier, Isabelle
    Millot, Frederic
    Lescoeur, Brigitte
    Gandemer, Virginie
    Bodemer, Christine
    Lacave, Roger
    Helias-Rodzewicz, Zofia
    Taly, Valerie
    Geissmann, Frederic
    Donadieu, Jean
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (25) : 3023 - +
  • [42] Detection of BRAF V600E mutation in radiological Langerhans cell histiocytosis-associated neurodegenerative disease using droplet digital PCR analysis
    Shimizu, Soichiro
    Sakamoto, Kenichi
    Kudo, Ko
    Morimoto, Akira
    Shioda, Yoko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (01) : 119 - 124
  • [43] Detection of BRAF V600E mutation in radiological Langerhans cell histiocytosis-associated neurodegenerative disease using droplet digital PCR analysis
    Soichiro Shimizu
    Kenichi Sakamoto
    Ko Kudo
    Akira Morimoto
    Yoko Shioda
    International Journal of Hematology, 2023, 118 : 119 - 124
  • [44] Langerhans Cell Sarcoma Arising from Small Lymphocytic Lymphoma: Lineage Analysis and BRAF V600E Mutation study
    Chen, Weiwei
    Jaffe, Ronald
    Block, Annemarie
    Sait, Sheila
    Song, Buer
    Cai, Donghong
    Liu, Yunguang
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 : 214 - 214
  • [45] Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA
    Dmitry Evseev
    Irina Kalinina
    Elena Raykina
    Daria Osipova
    Zalina Abashidze
    Anna Ignatova
    Anna Mitrofanova
    Alexey Maschan
    Galina Novichkova
    Michael Maschan
    International Journal of Hematology, 2021, 114 : 725 - 734
  • [46] Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA
    Evseev, Dmitry
    Kalinina, Irina
    Raykina, Elena
    Osipova, Daria
    Abashidze, Zalina
    Ignatova, Anna
    Mitrofanova, Anna
    Maschan, Alexey
    Novichkova, Galina
    Maschan, Michael
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (06) : 725 - 734
  • [47] A circulating subset of BRAFV600E-positive cells in infants with high-risk Langerhans cell histiocytosis treated with BRAF inhibitors
    Poch, Rita
    Le Louet, Solenne
    Helias-Rodzewicz, Zofia
    Hachem, Nawa
    Plat, Genevieve
    Barkaoui, Mohamed-Aziz
    Lapillonne, Helene
    Delhommeau, Francois
    Emile, Jean-Francois
    Donadieu, Jean
    Heritier, Sebastien
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (04) : 745 - 749
  • [48] Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with solid tumors with BRAF V600E/d/k/R mutation: Results from the targeted agent and profiling utilization registry (TAPUR) study
    Meric-Bernstam, Funda
    Rothe, Michael
    Garrett-Mayer, Elizabeth
    Gutierrez, Rodolfo
    Ahn, Eugene R.
    Cannon, Timothy Lewis
    Powell, Steven Francis
    Krauss, John C.
    Reynolds, Christopher M.
    Von Mehren, Margaret
    Behl, Deepti
    Calfa, Carmen Julia
    Duvivier, Herbert Leon
    Kaplan, Henry G.
    Livingston, Michael B.
    Sharma, Manish
    Urba, Walter John
    O'Lone, Raegan
    Halabi, Susan
    Schilsky, Richard L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] AGGRESSIVE LANGERHANS CELL HISTIOCYTOSIS FOLLOWING T-ALL: CLONALLY RELATED NEOPLASMS WITHOUT BRAF V600E MUTATION AND SUFFICIENT EXPRESSION OF ASPARAGINE SYNTHETASE
    Kitoh, Toshiyuko
    Akiyama, Masaharu
    Taki, Tomohiko
    Shimomura, Yasuto
    Hori, Toshinari
    Tsurusawa, Masahito
    Terashima, Tsuyoshi
    Yokoi, Toyoharu
    PEDIATRIC BLOOD & CANCER, 2014, 61 (11) : 2134 - 2134
  • [50] BRAF V600E Mutation in Melanoma, Colorectal Carcinoma, Hairy Cell Leukemia, Papillary Thyroid Carcinoma, and Langerhans Cell Histiocytosis: Concordance Between Molecular Testing and Mutation-Specific Immunohistochemistry
    Loo, Eric
    Khalili, Parisa
    Buehler, Karen
    Siddiqi, Imran
    Vasef, Mohammad
    LABORATORY INVESTIGATION, 2015, 95 : 518A - 519A